Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19
Clinical trial NCT04860518 · TERMINATED
Trial details
- NCT number
- NCT04860518
- Sponsor
- Faron Pharmaceuticals Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-23
- Primary completion
- 2022-04-04
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.